Search

Your search keyword '"Jara Palomares, L"' showing total 313 results

Search Constraints

Start Over You searched for: Author "Jara Palomares, L" Remove constraint Author: "Jara Palomares, L"
313 results on '"Jara Palomares, L"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

8. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

9. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

10. Timing and characteristics of venous thromboembolism after noncancer surgery

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

13. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

14. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

15. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

17. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

18. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

19. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

20. OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

21. OC 01.2 Oxygen vs Ambient Air in Patients with Intermediate-Risk Acute Pulmonary Embolism: The Air Randomized Clinical Trial

22. PB0479 The ABC-Bleeding Score for Prediction of On-Treatment Clinically Relevant Bleeding in Patients with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

23. PB1022 MicroRNAs Expression before and after Exercise in Patients with Residual Thrombosis after Pulmonary Embolism

24. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

25. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

26. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

27. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

28. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

30. DVT Management and Outcome Trends, 2001 to 2014

31. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis:a systematic review and meta-analysis

32. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

33. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

34. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

35. Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

36. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

37. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from de SLICE trial

38. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score

39. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

41. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

44. [Translated article] Multidisciplinary consensus for the management of pulmonary thromboembolism

45. Major bleeding in patients with pulmonary embolism presenting with syncope

46. Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism

47. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

48. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

50. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

Catalog

Books, media, physical & digital resources